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Abstract 
The expression of calmodulin kinase IV (CaMKIV) can be induced by the thyroid hormone T3 in a time- and concentration-dependent 
manner at a very early stage of brain differentiation using a fetal rat telencephalon primary cell culture system which can grow and 
differentiate under chemically defined conditions (Krebs et al. (1996) J. Biol. Chem. 271, 11055-11058). After the induction of CaMKIV 
by T 3 we examined the influence of prolonged absence of T3 from the culture medium on the expression of CaMKIV. We could 
demonstrate hat after the T3-dependent induction of CaMKIV, omission of the hormone, even for 8 days, from the medium did not 
downregulate he expression of CaMKIV indicating that different regulatory mechanisms became important for the expression of the 
enzyme. We further showed lhat CaMKIV could be involved in the Ca2+-dependent xpression of the immediate arly gene c-fos, 
probably via phosphorylation f the transcription factor CREB. Convergence of signal transduction pathways on this transcription factor 
by using different protein kinases may explain the importance of CREB for the regulation of different cellular processes. 
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1. Introduction 
Calcium ion is one of the most versatile second messen- 
gers involved in cell growth and differentiation [1]. It plays 
its pivotal role through a specific class of proteins, the 
so-called EF-hand type Ca2+-binding proteins [2], the most 
prominent representative of which is calmodulin (CAM) 
[3]. As an intracellular calcium-sensor calmodulin binds to 
and activates a great variety of enzymes, most notably a 
class of different protein kinases and phosphatase(s) - i.e., 
CaMkinases and calcineurin. Since protein kinases and 
phosphatases are key modulators of cellular regulatory 
processes, it is not surprising that CaMkinases are involved 
in the regulation of such central processes as neurotrans- 
mitter release, muscle contraction, cell proliferation and 
Abbreviations: CaM, calmodulin; CaMKII, Ca2+/CaM-dependent 
protein kinaseII; CaMKIV, Ca 2+/CaM-dependent protein kinase IV or 
Gr; CREB, cAMP response lement binding protein; IEG, immediate 
early gene; PBS, phosphate-buffered saline; SRF, serum response factor; 
T 3, 3,3',5-triiodo-L-thyronine. 
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gene expression (for reviews see Refs. [4] and [5]). Six 
different CaM-dependent kinases are known to date, all 
belonging to the class of enzymes phosphorylating serine- 
threonine residues. The targets can be either of multiple 
sources (e.g., CaMkinase I, II and IV) or dedicated to 
single substrates (e.g., myosin light chain kinase, phospho- 
rylase kinase or CaMkinase III). 
CaMkinase IV (CaMKIV) was first described as being 
particularly abundant in the granular cells of the cerebel- 
lum [6]. Therefore, the enzyme was called CaMkinase 'Gr' 
[6], but later the protein was renamed CaMkinase IV 
(CaMKIV) [7,8]. Next to nervous tissues CaMKIV is 
strongly expressed in the thymus, particularly in T- 
lymphocytes [9] and, to a somewhat lower extent, in the 
spleen and in testis, but is undectable in all other tissues 
examined [6,7,10,11]. 
The gene structure of CaMKIV has been reported re- 
cently [12]. The enzyme is expressed in two spliced iso- 
forms of M r 65 000 (a )  and of M r 67 000 (f l) ,  the latter 
being found mainly in the cerebellum [13]. The primary 
structure has been obtained by cDNA cloning from rat, 
mouse and human brain libraries [7,8,14-16]. The regula- 
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tory and catalytic domains of CaMKIV are highly homolo- 
gous to CaMKII, but the overall homology between the 
two enzymes is less than 50%. 
The substrate specificity of CaMKIV seems to be some- 
what restricted. Next to synapsin I [6] and the Ras related 
GTP-binding protein Raplb [17] mainly transcription fac- 
tors such as the cAMP regulatory element binding protein 
CREB [18,19], the serum response factor SRF [20,21] or 
members of the Ets family of transcription factors [22,23] 
could be phosphorylated by CaMKIV. Since CaMKIV has 
recently been reported to be located also in the nucleus 
[18,24], the enzyme could have direct access to transcrip- 
tion factors to regulate their function in a Ca 2 +-dependent 
manner. Thus it has been shown in different cell lines that 
CaMKIV is involved in the regulation of expression of 
IEGs either through CREB [18,19,25,26] or through SRF 
[21]. 
Since it was originally assumed that CaMKIV like 
CaMKII is activated by an autophosphorylating mecha- 
nism, the recent reports that autophosphorylation f 
CaMKIV was a slow and inefficient process [19,27], was a 
puzzling observation. Recombinant CaMKIV expressed 
either in Escherichia coli [28,29] or in baculovirus/Sf9 
cells [27,30] was activated by autophosphorylation only 
2-fold, even after incubation for 1-2 hours. This activation 
could be significantly improved by preincubation with 
brain extracts [28-30] out of which subsequently a CaMki- 
nase kinase could be purified and characterized [30-32]. 
This Ca2+/CaM-dependent enzyme of 66-68 kDa [30] 
could activate CaMKIV upto 30-fold within less than 1 
min [32,33]. Thus, CaMKIV involved in the regulation of 
gene transcription could be activated through a CaMkinase 
cascade, reminiscent of the regulation of mitogen activated 
protein (MAP)-kinase activity. 
Growth and differentiation of the mammalian brain has 
been shown to be controlled by different growth factors 
and hormones, among them the thyroid hormone 3,3',5-tri- 
iodo-L-thyronine T 3 [34,35]. T 3 acts through a specific 
receptor recognizing regulatory elements of the expressed 
gene like it has been described for other members of the 
superfamily of steroid/thyroid hormone receptors [36]. 
Recently, we reported the specific induction of CaMKIV 
by T 3 in a time- and concentration dependent manner [37]. 
This induction occurred at a very early stage of brain 
differentiation using a fetal rat telencephalon primary cell 
culture system which can grow and differentiate under 
chemically defined conditions [38]. It could be shown that 
the induction was T3-specific - i.e., the expression of 
CaMKIV could not be induced by either reverse T 3 or 
retinoic acid [37]. The expression of CaMKIV was regu- 
lated both on the transcriptional level and on the transla- 
tional level; e.g., the addition of actinomycinD as well as 
cycloheximide to the culture medium could prevent he 
T3-dependent induction of the enzyme. In addition, the 
T3-specific expression could be observed both on the 
mRNA and on the protein level [37]. Here we report hat 
CaMKIV could be involved in the regulation of expression 
of lEGs as it has been proposed by different Laboratories 
[18,25,39]. We could show that the expression of c-fos was 
significantly reduced provided T 3 (i.e., CaMKIV) was 
absent from those cultures. This reduction in the expres- 
sion of c-fos occurred only if the cells were depolarized by 
adding KC1 to the medium to promote Ca 2 +-influx. On the 
other hand, activation of the cells through other pathways 
- e.g., through protein kinase C - provided no difference 
in c-fos expression by comparing cultures grown in the 
presence or absence of T 3. Furthermore, we could demon- 
strate that the expression of CaMKIV, once started by 
adding T3, could not be downregulated by removing T 3 
from the medium as, by contrast, has been demonstrated, 
e.g., for myelin basic protein [40]. These findings suggest 
that the induction of CaMKIV by T 3 during rat brain 
development may be a terminal switch (i.e., CaMKIV 
could be instrumental in brain differentiation) possibly 
through the Ca2+-dependent regulation of expression of 
lEGs. 
2. Mater ia l s  and  methods  
2.1. Cell culture 
Serum-free, rotation-mediated aggregating cell cultures 
were prepared from fetal (15 days of gestation) rat telen- 
cephalon, as described in detail previously [37,38]. The 
culture medium used was Dulbecco's modified Eagle's 
medium (DMEM, Life Technologies, Gaithersburg, MD, 
USA), supplemented with nutritional factors, vitamins, 
trace elements, transferrin (1 mg/1), insulin (800 nM), and 
hydrocortisone-21 phosphate (20 nM). Gentamicin sulfate 
(25 mg/1) was used as an antibiotic. For analyses, the 
aggregates of each flask were washed twice with 5 ml of 
phosphate-buffered saline (PBS) and proteins were ex- 
tracted as described in [37]. 
2.2. Extraction of total cellular RNA and Northern blot 
analysis 
Total RNA was extracted according to the procedure of 
Gerstenfeld et al. [41] as described in detail elsewhere [42]. 
Briefly, after washing cell culture aggregates (grown for 5 
days either in the presence or absence of 3 × 10-8M T 3) 
with ice-cold phosphate-buffered saline the cells were 
lysed in a buffer containing 4 M guanidinium isothio- 
cyanate, 25 mM sodium acetate and 120 mM /3-mercapto- 
ethanol and sheared by 5 passages through a 21 gauge 
needle. Total RNA was purified by ultracentrifugation 
through cesium chloride as described by Chirgwin et al. 
[43]. RNA samples (10 /xg aliquots) were denatured by 
heating for 10 min at 55°C, electrophoretically separated 
on a 1.4% agarose/formaldehyde gel, transferred to Gene 
Screen filters by capillary blotting, and cross-linked to the 
15 filter by exposure to UV light for two minutes. After 
pro-hybridization for 6 hours at 65°C [42] the filters were 
hybridized with 32p-labeled probes (106cpm/ml) by incu- 
bation overnight at 65°C. SP6 recombinant transcripts of 
v-fos (685 bp SalI to PstI; [44]) and glyceraldehyde-phos- 
phate dehydrogenase (GAPDH; 1400 bp PstI; [45]) were 
used as riboprobes for the hybridization. After several 
washings [42] the filters were exposed to Amersham Hy- 
perfilm for 30 h at -80°C  using an intensifying screen. 
The levels of c-fos mRNA were determined by scanning 
densitometry, and normalized for differences in gel loading 
relative to the levels of GAPDH mRNA determined by 
rehybridization after stripping of the filters as described 
before [42]. 
2.3. Identification of CaMKIV 
In order to identify and characterize CaMK/V, aggre- 
gates of a total of 20 culture flasks (ca. 109 cells), grown 
for 5 days in the presence of T 3 (3 × 10-8M) have been 
collected, washed twice with ice-cold PBS and homoge- 
nized at 4°C in 3 vols. of ice-cold buffer containing 25 
mM Hopes (pH 7.5), 5 mM EGTA, 2 mM DTT, 1 mM 
PMSF, 1 mM leupeptine, 1 mM TPCK, 1 mM TLCK, 
1,10-Phenantroline, 1 mM p-aminobenzamidine. CaMKIV 
was isolated and identified as described in detail in Ref. 
[37]. Calmodulin-dependent kinase activity was character- 
ized by autophosphorylation using the assay as described 
by Cruzalegui and Means [27]. Identification of CaMKIV 
by specific antibodies kindly provided by Dr. A.R. Means, 
Durham, USA, was carried out by Western blotting using 
2% milk powder/PBS as blocking buffer. 
2.4. SDS-PAGE and electrophoretic blotting 
After extraction of the proteins from the pellet of whole 
aggregates (4-5 × 107 cells) as described in detail in [37], 
proteins were separated by SDS-PAGE [46] and elec- 
trophoretically blotted onto nitrocellulose sheets. CaM-bi- 
nding proteins were identified on the blots by incubation 
with ~25I-labeled CaM [47] and exposed to Phospholmager 
screens as described before [37]. Quantitation was obtained 
using the Phospholmager software as recommended by the 
manufacturers. 
3. Results 
As described in detail in [37] the expression of CaMKIV 
in fetal rat brain primary tissue cultures is induced by the 
thyroid hormone 3,3',5-triiodo-L-thyronine (T 3) in a dose 
and time dependent manner. Therefore, aggregating cell 
cultures from 15-day fetal rat telencephalon [37] were 
incubated for 5 days with increasing amounts of T 3. After 
collection of the cell pellets the proteins were extracted 
and separated by SDS-polyacrylamide g l electrophoresis, 
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Fig. 1. Quantification f the dose-dependent xpression of CaMKIV in 
response todifferent T 3 concentrations as described inSection 2; see also 
Ref. [37]. The values are given as relative intensities, etting the value for 
3×10 -~° MT 3 to 1. 
electrophoretically transferred onto nitrocellulose and 
CaM-binding proteins were identified by incubation with 
1251- labeled CaM [37]. CaMKIV was detectable already at 
very low concentrations of T 3 (3 X 10 - l°  M; Ref. [37]) 
and increased in intensity with increasing concentrations of
T 3 in the culture medium, indicating that the induction of 
CaMKIV by T 3 was dose-dependent. As demonstrated in
Fig. 1, quantitation of those results indicated a more than 
10 fold increase of CaMKIV expression by comparing the 
amount of protein induced by different T 3 concentrations. 
The induction of CaMKIV protein synthesis by T 3 was 
paralleled on the transcriptional level - i.e., CaMKIV 
mRNA was detectable only in cell cultures incubated with 
T 3 as  shown in [37]. 
If the mRNA and protein synthesis of CaMKIV were 
totally dependent on the presence of T 3, then removal of 
T 3 from the culture medium should downregulate the 
synthesis of CaMKIV. To test this hypothesis, cultures 
kDa 
CaMKIV 
~ 116 
97  
'~="  '===='  67 
45 
1 2 3 
Fig. 2. Prolonged expression of CaMKIV after emoval of T 3 from the 
culture medium. 125I-CaM overlay of extracts of fetal rat telencephalon 
cultures grown for 13 days in the absence (lane 1) or in the presence (lane 
2) of 3 × 10 -8 M T 3. Overlays of lane 3 have been made with extracts of 
cultures grown first for 5 days in the presence of 3?< 10 -s M T 3 and 
afterwards for 8 days in the absence ofthe hormone. Culture media were 
exchanged very other day. CaMKIV was identified as described indetail 
in Ref. [37]. The unresolved bands immediately below CaMKIV have 
been identified as Calcineurin A and CaMKIIfl, respectively. 
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grown for 5 days in the presence of 3 X 10 -8 M T 3 were  
exchanged with media not containing T 3 and cells were 
harvested at different ime intervals. As shown in Fig. 2 
CaMKIV could be detected, even if the cultures have been 
incubated up to 8 days with media lacking T 3 indicating 
that CaMKIV synthesis becomes independent of T3, once  
it had been induced by the hormone. Similar results could 
be obtained if the cultures had been analyzed already after 
3 or 5 days (data not shown). This is in contrast to findings 
obtained with the myelin basic protein [40] which is 
downregulated after emoval of T 3 from the culture medium 
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Fig. 3. Influence of CaMKIV on the expression of c-fos. (A) Autoradio- 
grams of gene screen filters after electroblotting, hybridization with 
probes for c-fos and GAPDH and exposure to film as described in detail 
in the Section 2. To each lane 10 /xg aliquots of RNA has been applied. 
The following conditions have been used for the different experiments: 
Cultures have been grown for 5 days either in the absence (lanes 2, 4, 6, 
8, 10, 12) or in the presence (lanes 1, 3, 5, 7, 9, 11) of 3×10 -8 M T 3. 
Lanes 1-4, controls, no stimulation; lanes 5-12, stimulation by incuba- 
tion of the cultures for 1 hour with either 30 mM KC1 (5-8) or with 100 
nM mezerein (9-12). To cultures of lanes 7, 8, 11, 12 1-fl-D-arabino-fur- 
anosylcytosine (Ara-C) has been added to prevent proliferation of glia 
cells and to enrich the cultures with neuronal tissue. The shown auto- 
radiogram is a representative of five different experiments. (B) Densito- 
metric quantification of data as shown in (A). The data were normalized 
relative to the data obtained for GAPDH and the value obtained with 30 
mM KCI in the presence of T 3 (lane 5) was set to 100%. The data given 
in the figure are an average of five different experiments, the error 
deviation is indicated. The numbers of the different lanes correspond to 
those of (A). 
for 24 h. These rather surprising results suggest hat after 
the induction of CaMKIV by T 3 which is essential for the 
initiation process as documented earlier [37], a different 
regulatory mechanism is dominating, indicating that proba- 
bly a different responsive lement becomes accessible after 
the induction by T 3. This could be under the control of a 
kinase, since preliminary experiments with the kinase in- 
hibitor staurosporine seem to indicate a downregulation of
CaMKIV in the presence of this inhibitor. 
As outlined before, CaMKIV may be involved in the 
transcriptional regulation of IEGs through the transcription 
factor CREB, originally identified as the cAMP regulatory 
element binding protein. If this were the case, then cell 
cultures grown in the presence or absence of T 3 should 
demonstrate a significant difference in the level of c-fos 
expression, which has been shown to be dependent on 
CREB mediating Ca 2+ responses [5]. As shown in Fig. 3 
the level of c-fos mRNA differed significantly depending 
on the process of stimulation. If the cells have been 
incubated with 100 nM mezerein for 1 hour to stimulate a
protein kinaseC pathway, the level of c-fos was practically 
identical comparing cultures grown in the presence or 
absence of T 3. However, by incubating the cells with 30 
mM KCI to achieve membrane depolarization and subse- 
quent Ca2+-influx into the cells a significant decrease of 
c-fos induction could be noticed in the absence of T 3 (i.e., 
in the absence of CaMKIV), suggesting that CaMKIV may 
be involved in the CaZ+-dependent stimulation of c-fos 
expression. This difference in c-fos expression became 
even more visible if the cultures had been pretreated with 
1-/3-D-arabino-furanosylcytosine (Ara-C) to prevent prolif- 
eration of glia cells and to enrich the cultures with neu- 
ronal tissues, since CaMKIV is highly expressed in neu- 
rons as described before [37]. As shown in Fig. 3B, by 
normalizing the expression of c-fos to the level of GAPDH 
expression, less than 50% of c-fos were expressed in the 
absence of CaMKIV if the cells were stimulated by mem- 
brane depolarization, whereas no difference could be no- 
ticed if the cells had been stimulated in a Ca2+-indepen - 
dent manner. 
4. Discussion 
In this and in an earlier contribution [37] we have 
provided compelling evidence that CaMKIV is induced by 
the thyroid hormone T 3 during the early stages of embry- 
onal brain development. The expression of the enzyme is 
dose- and time-dependent, is controlled on the transcrip- 
tional level and is T 3 specific - i.e., neither everse  T 3 nor 
retinoic acid nor other growth factors can stimulate 
CaMKIV expression. The kinase may be specifically ex- 
pressed in neurons, since the enzyme was found at high 
levels in neuron-enriched aggregate cultures in which 
highly proliferating lial cells have been suppressed by the 
addition of 1-/3-D-arabino-furanosylcytosine (Ara-C) [48]. 
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It was interesting to note that the expression of CaMKIV 
could be induced by the addition of T 3 to the culture 
medium, but that removal of T 3 did not turn off the 
synthesis of the enzyme. This is typical for a terminal 
switch during cell differentiation, similar to observations 
during muscle differentiation [49]. Recent experiments 
seem to indicate that differentiation processes of neurons 
in these cell aggregates were significantly reduced if 
CaMKIV was either inhibited or not expressed (Krebs and 
Honegger, unpublished observations). This was especially 
noticeable for cholinergic neurons in contrast to GABAer- 
gic neurons or to glia cells. 
In the developing brain, synaptic connectivity of neu- 
rons may be critically dependent on rapid genomic re- 
sponses to neuronal stimulation. A group of genes that is 
rapidly and transiently activated by growth factors and 
other stimulatory mechamsms are referred to as 'im- 
mediate arly genes' (IEGs), a member of which is c-fos. 
A number of IEGs code for transcription factors such as 
members of the fos and jun families, which dimerize to 
form the transcription regulatory complex AP-1. Neuronal 
stimulation, both in vitro and in vivo, can activate c-fos, as 
well as other lEGs encoding transcription factors control- 
ling the expression of late response genes important for 
neuronal plasticity and excitability [50]. There is ample 
evidence that several signal transduction pathways can 
enhance the expression of c-fos, the best characterized 
system modulating the expression through the transcription 
factor CREB [51]. As indicated before, CREB binds to the 
cAMP responsive lement (CRE) of several genes, and 
initiation of gene transcription requires phosphorylation f
Ser 133 [52]. CREB can be phosphorylated not only by 
cAMP dependent protein kinase [52], but also by CaMki- 
nases [18,19,39] thereby suggesting a mechanism to ex- 
plain the Ca2+-dependent regulation of expression of 
CRE-containing enes such as c-fos [39]. In the present 
paper we provided evidence that CaMKIV could be in- 
volved in the regulation of c-fos expression in a primary 
brain tissue culture system, possibly through the phospho- 
rylation of CREB, since Ca2+-dependent stimulation of 
c-fos expression was downregulated in the absence of 
CaMKIV (Fig. 3). Of course, the given evidence is only 
indirect and other explanations could be possible, but the 
conclusions drawn upon the results described before are 
the most straightforward. Similar observations have been 
made by Enslrn and Soderling [25] reporting that in PC12 
cells Ca2+-dependent expression of c-fos and other IEGs 
were modulated by a member of the CaMkinase family 
since calcium-dependent transcription could be inhibited 
by the CaMkinase-specific inhibitor KN-62. In this context 
it is of interest hat Matthews et al. [18] by using trans- 
fected JEG-3 cells provided evidence that only CaMKIV, 
but not CaMKII, was able to transactivate a CRE-contain- 
ing reporter gene in transient expression assays through 
phosphorylation f CREB. The authors provided evidence 
that the difference in activation may depend on the ability 
Ca 2+ 
cAMP~, Ca~VlKK CaM~, 
S-133 
~ 142 c-fos 
L 
Fig. 4. Schematic view of different signal transduction pathways converg- 
ing on CREB. The scheme summarizes the influence of different kinases 
on CREB phosphorylation nvolved in different Ca2+-dependent path- 
ways as discussed in the text, and is based also on observations described 
in Refs. [18,39,52]. The following abbreviations have been used: 
CaMKII,IV = calmodulin-dependent kinase II,IV; CaMKK = calmodulin- 
dependent kinase kinase; CREB = cAMP-dependent regulatory element 
binding protein; PKA = cAMP-dependent protein kinase, The signs (+) 
indicate upregu|ation a d ( - )  downregulation of the c-los expression. 
that only CaMKIV could translocate to the nucleus [18]. In 
addition, Sun et al. [26] reported recently that CaMKII 
could phosphorylate CREB not only on residue Ser-133, 
but also on Ser-142, the latter having an inhibitory influ- 
ence on CREB activity. This may explain the recent 
finding of Nghiem et al. [53] who reported that in Jurkat 
T-cells transfected with a constitutively active mutant of 
CaMKII, expression of interleukin-2 (11-2) was downregu- 
lated by more than 90%. Since 11-2 expression is mainly 
controled via the transcription factors NFAT and AP-1, the 
latter being a heterodimer of c-Fos and c-Jun, it could be 
suggested that downregulation of I1-2 could occur through 
inhibition of CREB controlling c-Fos expression. It is 
interesting that Nghiem et al. [53] indeed found that 
CaMKII significantly decreased stimulated transcription 
from AP-1. In Fig. 4 we provide a schematic view of the 
different signal transduction pathways which may con- 
verge at the phosphorylation a d subsequent activation or 
inhibition of CREB. 
In conclusion, our results indicate that during rat brain 
development the expression of CaMKIV, not detectable at 
the early stages of ontogenesis (i.e., at El5), is induced by 
the thyroid hormone in a time- and concentration-depen- 
dent manner, but once the gene has been turned on, the 
expression becomes T3-independent suggesting that an ad- 
ditional regulatory mechanism is involved in CaMKIV 
expression. Whether this T3-dependent regulation is due to 
a direct interaction of the T3-receptor with a responsive 
element of the CaMKIV gene [36] or whether the effect is 
indirect remains to be determined. Furthermore, our results 
indicated that the Ca2+-dependent expression of the IEG 
c-fos could, at least partly, be regulated by CaMKIV, since 
the expression of c-fos was more than 50% reduced in the 
absence of CaMKIV. Since CaMKIV seems to play an 
important role in rat brain development, as our results 
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indicate, it will be now of interest to know, whether in the 
immune system CaMKIV is under the control of the 
thyroid hormone, too, or whether different signals regulate 
the expression. Preliminary results indicate that the synthe- 
sis of CaMKIV in the rat embryonal thymus is induced 
following the same time-course as in the embryonal brain. 
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